G-N Franke - Med Klin Hamatol Zelltherapie & Hamostaseol 1, Univ Klinikum Leipzig

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

T-TAS HD-Chip in patients with myeloid neoplasia and thrombocytopenia

K. Freitag, A. Siegemund, K. Metzeler,G.-N. Franke, S. Petros, U. Platzbecker, C. Pfrepper

GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Buil...（2024）

引用0浏览0引用

Prognostic relevance of the 2022 European LeukemiaNet risk classification in acute myeloid leukemia (AML) patients undergoing allogeneic stem cell transplantation (HSCT)

M. Jentzsch, L. Bischof, J. Ussmann, D. Backhaus, D. Brauer, K. H. Metzeler, M. Herling, M. Merz, V. Vucinic,G. -N. Franke, U. Platzbecker, S. Schwind

ONCOLOGY RESEARCH AND TREATMENT (2023): 192-192

引用0浏览0引用

Stem cell mobilization and collection after anti-CD38mab-based induction therapy in newly diagnosed multiple myeloma

R. Teipel, K. Hoelig, S. Rieprecht, C. Kloetzer, K. Trautmann-Grill, C. Roellig, K. Zimmer, G. Rathaj, E. Bach, M. Brueckner, S. Heyn, S. Y. Wang,

ONCOLOGY RESEARCH AND TREATMENT (2023): 234-234

引用0浏览0引用

M. Lorch, M. Pfirrmann,C. Fabisch, L. Oberle, D. Kohn, K. Kohlbrenner,T. H. Bruemmendorf,A. Burchert, S. W. Krause,P. le Coutre,M. Haenel,G-N Franke,

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Red blood cell Distribution Width (RDW) at diagnosis of Acute Myeloid Leukemia (AML) as a marker for non-relapse mortality after allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

V. Vucinic, D. Backhaus, D. Brauer,G-N Franke,D. Niederwieser, U. Platzbecker,S. Schwind,M. Jentzsch

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations

C. Niederwieser,S. Starke, L. Fischer,R. Krahl,J. Beck,B. Gruhn,W. Ebell, D. Körholz, W. Wößmann,P. Bader,P. Lang, H-K. Al-Ali,

Annals of Hematology（2015）

引用4浏览0WOS引用

Allogeneic haematopoietic stem cell transplantation (HCT) with reduced intensity conditioning (RIC) is a feasible therapeutic option in older or comorbid patients (pts) with acute lymphoblastic leukemia (ALL)

T. Tumewu,G-N Franke,S. Schwind,N. Jaekel, S. Heyn,W. Poenisch,H. K. Al-Ali,S. Leiblein,R. Krahl,M. Jentzsch, G. Behre,D. Niederwieser,

Oncology Research and Treatmentno. SUPnan (2014): 46.0-46

引用0浏览0引用

High pretreatment miR-181a-1 and/or miR-181a-2 expression in intermediate risk acute myeloid leukemia (AML) patients (pts) associates with lower relapse rates after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT)

S. Schwind,M. Jentzsch,T. Lange,W. Poenisch, S. Heyn,V. Vucinic,G-N Franke,R. Krahl,N. Jaekel,H. Al-Ali,M. Cross, G. Behre,

ONKOLOGIEno. SUPnan (2013): 192-192

引用0浏览0引用

Monitoring of WT1 expression in PB and CD34 + donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning

T Lange, M Hubmann,R Burkhardt,G-N Franke,M Cross,M Scholz,S Leiblein,H K Al-Ali,J Edelmann,J Thiery,D Niederwieser

LEUKEMIA（2010）

引用70浏览0WOSNATURE引用

G-N. Franke,S. Leiblein,E. Hennig,D. Niederwieser,T. Lange

BONE MARROW TRANSPLANTATION（2009）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn